STRATA Historical Financial Ratios
| SSKN Stock | USD 3.00 0.01 0.33% |
STRATA Skin is promptly reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 3.45, Invested Capital of 0.0, Average Payables of 467.2 K or Stock Based Compensation To Revenue of 0.0371 will help investors to properly organize and evaluate STRATA Skin Sciences financial condition quickly.
STRATA |
About STRATA Financial Ratios Analysis
STRATA Skin SciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate STRATA Skin investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on STRATA financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across STRATA Skin history.
STRATA Skin Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing STRATA Skin Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on STRATA Skin sales, a figure that is much harder to manipulate than other STRATA Skin Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Ev To Free Cash Flow
A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.Most ratios from STRATA Skin's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into STRATA Skin Sciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. At this time, STRATA Skin's PTB Ratio is very stable compared to the past year. As of the 4th of December 2024, Days Sales Outstanding is likely to grow to 72.64, while Price To Sales Ratio is likely to drop 0.55.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 3.59 | 4.2 | 4.46 | 3.52 | Days Of Inventory On Hand | 125.75 | 140.67 | 65.49 | 62.22 |
STRATA Skin fundamentals Correlations
Click cells to compare fundamentals
STRATA Skin Account Relationship Matchups
High Positive Relationship
High Negative Relationship
STRATA Skin fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 2.11 | 2.18 | 1.66 | 0.76 | 0.58 | 0.55 | |
| Ptb Ratio | 2.32 | 1.95 | 1.96 | 1.26 | 1.51 | 1.59 | |
| Days Sales Outstanding | 50.68 | 46.54 | 41.8 | 45.13 | 48.58 | 72.64 | |
| Book Value Per Share | 8.96 | 7.7 | 7.46 | 6.29 | 3.63 | 3.45 | |
| Free Cash Flow Yield | (0.008448) | (0.00125) | (0.043) | (0.17) | (0.29) | (0.3) | |
| Operating Cash Flow Per Share | 0.7 | 0.62 | 0.44 | (0.32) | (0.15) | (0.16) | |
| Stock Based Compensation To Revenue | 0.0378 | 0.0707 | 0.0548 | 0.0405 | 0.0391 | 0.0371 | |
| Capex To Depreciation | 0.58 | 0.55 | 0.89 | 0.62 | 0.85 | 0.81 | |
| Pb Ratio | 2.32 | 1.95 | 1.96 | 1.26 | 1.51 | 1.59 | |
| Ev To Sales | 2.06 | 2.12 | 2.2 | 1.51 | 0.84 | 0.8 | |
| Free Cash Flow Per Share | (0.18) | (0.0187) | (0.63) | (1.34) | (1.59) | (1.67) | |
| Roic | (0.0695) | (0.12) | (0.13) | (0.16) | (0.3) | (0.32) | |
| Inventory Turnover | 3.74 | 2.6 | 2.9 | 2.59 | 5.57 | 5.85 | |
| Net Income Per Share | (1.18) | (1.31) | (0.79) | (1.6) | (3.1) | (3.26) | |
| Days Of Inventory On Hand | 97.64 | 140.36 | 125.75 | 140.67 | 65.49 | 62.22 | |
| Payables Turnover | 6.02 | 3.24 | 3.59 | 4.2 | 4.46 | 3.52 | |
| Sales General And Administrative To Revenue | 0.29 | 0.33 | 0.34 | 0.32 | 0.28 | 0.3 | |
| Research And Ddevelopement To Revenue | 0.0317 | 0.0552 | 0.0478 | 0.0285 | 0.0395 | 0.0375 | |
| Capex To Revenue | 0.0884 | 0.0935 | 0.12 | 0.0982 | 0.15 | 0.14 | |
| Cash Per Share | 2.54 | 3.15 | 3.7 | 1.57 | 1.94 | 1.85 | |
| Pocfratio | 29.85 | 24.05 | 33.08 | (24.75) | (37.01) | (38.86) | |
| Capex To Operating Cash Flow | 1.25 | 1.03 | 2.42 | (3.21) | (9.67) | (9.19) | |
| Pfcf Ratio | (118.37) | (800.24) | (23.26) | (5.88) | (3.47) | (3.64) | |
| Days Payables Outstanding | 60.64 | 112.65 | 101.71 | 86.86 | 81.91 | 116.45 | |
| Income Quality | (0.59) | (0.48) | (0.56) | 0.2 | 0.0479 | 0.0455 | |
| Ev To Operating Cash Flow | 30.09 | 24.19 | 30.06 | (27.46) | (54.06) | (51.35) | |
| Pe Ratio | (17.55) | (11.43) | (18.43) | (4.94) | (1.77) | (1.86) | |
| Ev To Free Cash Flow | (119.33) | (804.66) | (21.13) | (6.53) | (5.07) | (5.32) | |
| Earnings Yield | (0.057) | (0.0875) | (0.0542) | (0.2) | (0.56) | (0.59) | |
| Intangibles To Total Assets | 0.39 | 0.35 | 0.32 | 0.41 | 0.5 | 0.33 | |
| Net Debt To E B I T D A | 0.3 | (1.68) | (2.64) | 2.67 | (2.62) | (2.49) | |
| Current Ratio | 1.35 | 1.32 | 1.56 | 1.3 | 1.28 | 1.21 | |
| Tangible Book Value Per Share | 3.72 | 3.2 | 1.92 | (1.26) | (0.33) | (0.31) | |
| Receivables Turnover | 7.2 | 7.84 | 8.73 | 8.09 | 7.51 | 5.82 | |
| Graham Number | 15.46 | 15.08 | 11.55 | 15.04 | 15.92 | 15.13 | |
| Shareholders Equity Per Share | 8.96 | 7.7 | 7.46 | 6.29 | 3.63 | 3.45 |
Pair Trading with STRATA Skin
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.Moving against STRATA Stock
The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.
The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share 9.347 | Quarterly Revenue Growth 0.022 | Return On Assets (0.07) | Return On Equity (0.63) |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.